Short‐course versus long‐course antibiotic therapy for non‐severe community‐acquired pneumonia in children aged 2 months to 59 months
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Short‐course Versus Long‐course Antibiotic Therapy for Non‐severe Community‐acquired Pneumonia in Children Aged 2 Months to 59 Months." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433210/2/repview. Accessed 03 May 2024.
Short‐course versus long‐course antibiotic therapy for non‐severe community‐acquired pneumonia in children aged 2 months to 59 months. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433210/2/repview. Accessed May 3, 2024.
Short‐course versus long‐course antibiotic therapy for non‐severe community‐acquired pneumonia in children aged 2 months to 59 months. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433210/2/repview
Short‐course Versus Long‐course Antibiotic Therapy for Non‐severe Community‐acquired Pneumonia in Children Aged 2 Months to 59 Months [Internet]. In: Cochrane Abstracts. [cited 2024 May 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433210/2/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Short‐course versus long‐course antibiotic therapy for non‐severe community‐acquired pneumonia in children aged 2 months to 59 months
ID - 433210
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433210/2/repview
DB - Evidence Central
DP - Unbound Medicine
ER -